Medgenix Pharma India Pvt Ltd
Gandhi Medicos: Global Leaders in Authentic Healthcare and a Range of Medgenix Pharma Products
Medgenix Pharma
Medgenix Pharma is an Indian Pharmaceutical company that manufactures a wide range of generic and ethical finished dose formulations in diverse therapeutic segments.
Medgenix Product Portfolio at Gandhi Medicos
- Anticancer Medicines
- Cardiovascular Medicines
- Gastrointestinal Medicines
- Nutraceuticals
Certified Quality at Gandhi Medicos
We outsource only the certified pharmaceuticals –
- WHO-GMP, EU-GMP certified
- Verified batch numbers and expiry dates
- Authentic labels and trademarks
- Original packaging
Global Reach and Distribution
Committed to providing authentic healthcare solutions, affordable to all, we operate globally with strong footprints in Africa, America, Europe, and Southeast Asia.
- 50+ countries
- 800+ cities
20 Years of Pharmaceutical Excellence
We are the preferred choice for healthcare professionals and are the global suppliers for bulk therapeutics to hospitals, clinics, and medical centers.
- 25000+ satisfied customers
- 3000+ monthly prescription fillings
Unparalleled Therapeutic Range
We offer the widest range of Global pharmaceutical products, leading brands, and premium quality generics.
300+ global brands
400+ generics
3000+ products
Integrated Supply Chain
- Timely delivery
- Intact cold chain
- Traceable shipments
- Real-time temperature monitoring
Customer Care Support
Our CRM team experts offer end-to-end services and assist at every step from order placement to order procurement.
- Timely response
- Expert advice
- Multichannel communication
- Safe and easy transactions
Gandhi Medicos – Premium Healthcare Partner, Trusted Worldwide.
Formulations associated with "Medgenix Pharma India Pvt Ltd" (1)

Mycograft 180mg Tablet
Mycophenolate Sodium
Immunosuppressants are the class of medications Mycograft 180mg Tablet belongs to. With other medications, it is used to prevent your body from rejecting a new organ (such as a liver, kidney, or he...
